Axil Brands, Inc. AXIL
sale, and distribution of high tech hearing and audio enhancement and protection products, professional quality hair and skin care products,
and the delivery of marketing services. The Company changed its name from Reviv3 Procare Company to AXIL Brands, Inc. effective February
14, 2024 and concurrently uplisted to the NYSE American stock exchange. The Company operates through its subsidiaries, AXIL Distribution
Marketing Inc., which was incorporated on May 5, 2025. In February 2026, the Company formed Reviv3 ProCare Company, a wholly owned Delaware
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $30.8M | $26.3M | $27.5M | $23.5M | $2.3M | $1.6M | $1.0M | $992.7K | $933.2K | $582.0K |
| Cost of revenue | $9.4M | $7.6M | $7.3M | $5.8M | $828.6K | $599.7K | $480.8K | $553.0K | $576.2K | $281.6K |
| Gross profit | $21.4M | $18.6M | $20.2M | $17.7M | $1.5M | $1.0M | $531.9K | $439.7K | $357.0K | $300.4K |
| SG&A | $4.1M | $4.1M | $1.6M | $1.3M | $271.9K | $281.9K | $270.3K | $267.1K | $221.2K | $244.0K |
| Total operating expenses | $18.4M | $17.5M | $18.7M | $15.7M | $1.7M | $1.4M | $703.1K | $589.3K | $695.8K | $838.6K |
| Operating income | $3.0M | $1.2M | $1.5M | $2.0M | -$211.4K | -$321.1K | -$171.1K | -$149.6K | -$338.8K | -$538.2K |
| Interest expense | $2.6K | $3.9K | $4.4K | $2.5K | $6.5K | $6.1K | $1.8K | $471 | $3.8K | $576 |
| Pre-tax income | $3.1M | $1.3M | $1.8M | $2.1M | -$182.9K | -$297.8K | -$172.8K | -$150.0K | -$342.5K | -$538.8K |
| Income tax | $440.3K | $453.8K | $220.2K | $230.9K | — | — | — | — | — | — |
| Net income | $2.7M | $855.0K | $2.0M | $1.8M | -$182.9K | -$297.8K | -$172.8K | -$150.0K | -$342.5K | -$538.8K |
| EPS, basic | 0.40 | 0.13 | 0.57 | 0.32 | 0.00 | — | — | — | — | — |
| EPS, diluted | 0.33 | 0.10 | 0.21 | 0.10 | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| Shares, diluted (wtd. avg.) | $8.3M | $8.2M | $16.2M | $17.9M | $41.9M | — | — | — | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $4.5M | $4.8M | $3.3M | $4.8M | $373.7K | $496.9K | $409.0K | $346.2K | $227.9K | $416.9K |
| Inventory | $4.4M | $2.5M | $3.4M | $1.3M | $323.4K | $490.9K | $288.1K | $264.6K | $321.5K | $129.8K |
| Total current assets | $14.3M | $9.3M | $8.0M | $7.4M | $803.0K | $1.0M | $893.1K | $693.3K | $586.3K | $613.6K |
| Property, plant and equipment | $389.7K | $412.3K | $260.9K | $157.5K | $29.1K | $37.0K | $31.6K | $32.8K | $8.3K | $7.3K |
| Goodwill | $2.2M | $2.2M | $2.2M | $2.2M | — | — | — | — | — | — |
| Other intangibles | $389.7K | $403.6K | $309.1K | $382.7K | — | — | — | $474 | — | — |
| Total assets | $18.0M | $12.9M | $11.0M | $10.2M | $893.9K | $1.3M | $1.1M | $741.5K | $609.5K | $635.7K |
| Accounts payable | $2.0M | $866.6K | $967.6K | $908.6K | $458.3K | $459.0K | $128.9K | $32.5K | $79.8K | $63.0K |
| Total current liabilities | $4.5M | $2.5M | $2.8M | $2.9M | $707.0K | $712.4K | $339.8K | $52.2K | $96.2K | $83.2K |
| Long-term debt | — | $140.2K | $146.6K | $172.6K | — | — | — | — | — | — |
| Total liabilities | $4.8M | $3.2M | $3.3M | $3.5M | $709.2K | $917.1K | $638.3K | $64.1K | $96.2K | $83.2K |
| Retained earnings | $3.4M | $720.7K | -$134.3K | -$3.5M | -$5.3M | -$5.1M | -$4.8M | -$4.6M | -$4.5M | -$4.1M |
| Total equity | $13.1M | $9.7M | $7.7M | $6.7M | $184.7K | $345.6K | $504.6K | $677.4K | $513.3K | $552.5K |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$9.6K | $1.9M | $2.7K | $2.9M | -$126.1K | $48.4K | -$89.7K | -$175.0K | -$468.5K | -$370.0K |
| Depreciation and amortisation | $246.7K | $148.5K | $35.0K | $95.2K | $7.9K | $10.0K | $10.5K | $5.9K | $3.0K | $1.4K |
| Stock-based compensation | $785.2K | $1.1M | $267.2K | $207.3K | $22.0K | $138.8K | — | $5.0K | $32.1K | $131.3K |
| Capital expenditure | $79.4K | $213.5K | $138.4K | $65.7K | — | $15.4K | $9.2K | $13.9K | $4.1K | $5.5K |
| Investing cash flow | -$210.3K | -$394.3K | -$160.5K | $1.0M | — | -$15.4K | -$9.2K | -$14.4K | -$4.1K | -$5.5K |
| Financing cash flow | -$87.8K | -$18.4K | -$1.4M | $540.1K | $2.8K | $54.9K | $161.8K | $307.7K | $283.6K | $422.6K |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001520138-26-000360.
Others in SIC 2844
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| CL | COLGATE PALMOLIVE CO | $70.77B | 33.8x | 1.4% |
| EL | ESTEE LAUDER COMPANIES INC | $37.63B | 207.7x | 5.0% |
| KVUE | Kenvue Inc. | $36.00B | 24.7x | -2.1% |
| ELF | e.l.f. Beauty, Inc. | $6.47B | 249.2x | 24.6% |
| IPAR | INTERPARFUMS INC | $3.74B | 22.3x | 2.5% |
| COTY | COTY INC. | $2.58B | — | -1.5% |
| EPC | EDGEWELL PERSONAL CARE Co | $1.33B | 54.5x | -1.3% |
| WALD | Waldencast plc | $156.3M | — | -0.7% |